The @Pfizer/@BioNTech_Group vaccine trial is complete for efficacy. Of 43,661 participants, 170 events, 162 in placebo group, 8 in the vaccine. That's 95% efficacy; *phenomenal*; replicated @moderna_tx, ~ as good as it gets👇
statnews.com/2020/11/18/pfi… @damiangarde @matthewherper
statnews.com/2020/11/18/pfi… @damiangarde @matthewherper
The only silver lining of rampant covid spread in the US is that the vaccine trials are getting completed much faster
Good timing for this FAQ today @washingtonpost washingtonpost.com/health/2020/11… by @Carolynyjohnson @asteckelberg @PostGraphics
Short answer: They work really well
We'll see all the data, w/ safety, very soon at external advisory mtg
Infographic: where we go from here, important stuff
Short answer: They work really well
We'll see all the data, w/ safety, very soon at external advisory mtg
Infographic: where we go from here, important stuff
This updated vaccine assessment by @DerekLowe, who tells it like it is, is especially upbeat and worthwhile
blogs.sciencemag.org/pipeline/archi…
1. Durability of the immune response & likely vaccine protection
2. Low likelihood of vaccinated, asymptomatic carriers
3. Short-term safety👍
blogs.sciencemag.org/pipeline/archi…
1. Durability of the immune response & likely vaccine protection
2. Low likelihood of vaccinated, asymptomatic carriers
3. Short-term safety👍
• • •
Missing some Tweet in this thread? You can try to
force a refresh
